DayFR Euro

James Van Der Beek, ex-Dawson star, announces he suffers from colon cancer

American actor James Van Der Beek, lead actor in the series “Dawson” has revealed that he has colon cancer. However, he says he is “optimistic” about his chances of remission.

An announcement that could upset fans. This Sunday, November 3, People magazine revealed that American actor James Van Der Beek was suffering from colon cancer. The person concerned himself confirmed this to the newspaper, ensuring that he was “trying to face this diagnosis privately” and taking “steps to resolve it, thanks to the support of my incredible family”.

James Van Der Beek then assured that “there were reasons to be optimistic” and that he “felt good” despite this diagnosis. No details were given on the progress of his illness. Aged 47, he is the father of six children with his wife Kimberly Brook.

After initial forays into cinema and television, James Van Der Beek became an international star through the series “Dawson”, broadcast between 1999 and 2003 in . He played the character of Dawson Leery, a teenager wishing to become a film director. At the time, this production struck spectators for its very crude dialogues and themes (sexuality, addiction and even homophobia), while regularly breaking the fourth wall.

The actor, however, had a lot of difficulty getting out of his role, being very little requested in the cinema by Hollywood. On television, James Van Der Beek was only entitled to short appearances in “Ugly Betty”, “Criminal Minds” or even “How I Met Your Mother” and had to wait for “CSI: Cyber” to be on newly cast in a leading role.

The actor is however active, having recently appeared in the reboot of the series “Walker” and will be visible in the film “Sidelined: The QB and Me”, by Justin Wu, the release date of which is still unknown in France.

According to People, James Van Der Beek will appear on American television next month for a 2-hour special, “The Real Full Monty,” where a group of male celebrities will promote prevention and research for colorectal cancers. , prostate and testicles.

-

Related News :